KUALA LUMPUR: Pharmaniaga Bhd
is looking to expand its presence in Southeast Asia and Africa by supplying finished Sinovac COVID-19 vaccine manufactured by its own high-technology plant.
Group managing director Datuk Zulkarnain Md Eusope said the Southeast Asian region, with a population of over 700 million, and the African continent, with its 1.3 billion population, offered tremendous potential for growth and would be the company’s focus areas to supply the vaccine.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
